Spiros N. Agathos, Ph.D. is Professor of Bioengineering at the Université Catholique de Louvain (UCL) in Louvain-la-Neuve, Belgium since 1993 and, since 2015, he is Inaugural Dean of Biological Sciences and Engineering at Yachay Tech, the first research-intensive university in Ecuador and a hub of innovation in South America.
He is an expert in Biotechnology and Bioengineering, with interests in biocatalyst development, bioprocess optimisation, bioreactor design and scale-up, ecogenomics, and biotechnology for sustainability. He has a PhD in biochemical engineering from the Massachusetts Institute of Technology (MIT) and served on the faculties of the University of Western Ontario (Canada) and Rutgers University (New Jersey, USA) and as a visiting professor in Europe and the Americas.
He has published over 200 articles, 4 books and 4 patents. He has been Editor or Editorial Board member of many journals and serves on numerous committees for science and technology policy. He is a consultant to governments and industry, while his former students and postdocs have significant academic and industrial positions across the globe. Among his many awards, he is an elected Fellow of the American Institute for Medical & Biological Engineering (AIMBE), of the Society for Industrial Microbiology & Biotechnology (SIMB) and of the International Water Association (IWA).
Associate Prof. of Bioengineering, University of Pisa, Head of In-Vitro Models Group and NanoBioscopy Lab at the National Council of Research Institute of Clinical Physiology (CNR-IFC). Also involved in capacity building in the field of Biomedical Engineering, in association with UNECA and FABLAB Pisa .Author of over 100 peer-reviewed publications and of several patents on microfabrication and on bioreactors, co-founder of 2 high-tech companies.
Training: Dentistry, Biomedical Research, Bioengineering, Pathology
Postdoctoral: TGF-beta, wound healing, regeneration, radiation biology, light biology, stem cells, biomaterial, Lasers.
Current: Clinical translational research and molecular mechanism.
Positions: Past-President, NAALT; President-Elect WALT, Co-Chair SPIE, Chair, ASLMS
Interests: Signal Transduction, Lasers, Biological regulation, Photobiomodulation.
INSERM Tenured Researcher in the field of Cardiovascular Research, currently focusing on therapeutic angiogenesis with polymer-based targeted growth factor delivery.
PhD in Tumor Biology (Pr Yihai Cao, Karolinska Institutet, Sweden), and expertise in Adipose tissue angiogenesis. Postdoc at UCLA (Pr Lily Wu) in molecular imaging and tumor lymphangiogenesis field.
Member of European Vascular Biology Organisation, French society for Cardiovascular Research, French society for Angiogenesis Research.
E. Ada Cavalcanti-Adam is a research group leader at the Institute of Physical Chemistry, University of Heidelberg and head of Central Scientific Facility “Biomaterials and Molecular Biology” at the Max Planck Institute for Intelligent Systems in Stuttgart. Her main research interest is on extracellular stimuli which guide cell structure and functions with a special focus on the role of growth factors on cell adhesion and migration.
Professor of Biomedical Engineering, Mechanical Engineering at The University of Hong Kong.
Albert Cheng obtained his BSc in Biochemistry and MPhil in Biology from Hong Kong University of Science and Technology in 2005 and 2007, respectively. He studied neurotrophin signaling and C. elegans developmental genetics. He then pursued his PhD in Computational & Systems Biology at MIT in the labs of Profs Christopher Burge and Rudolf Jaenisch and worked on various topics on epigenetics, gene regulation and alternative splicing in stem cells, reprogramming, cancer metastasis, erythropoiesis and differentiation. Cheng and colleagues identified H3K27ac as a signature for active enhancers. He analyzed alternative splicing in epithetlial-mesenchymal transition, cancer metastasis as well as erythropoiesis and identified splicing factors regulating these processes. He constructed CRISPR-on, an artificial RNA-guided activator based on CRISPR/Cas. After graduating in 2014, he joined the Jackson Laboratory at Bar Harbor, ME, as one of the first JAX scholars where he continued to work on understanding and improving the CRISPR/Cas technology. In July 2015, he started his own lab as an assistant professor at the Jackson Laboratory for Genomic Medicine campus at Farmington, CT.
Associate Professor, Bioengineering, University of California, Merced.
I am Associate Professor of Applied Physics, Director of the BIND – Behavioral Imaging and Neural Dynamics Center, and affiliated to the Department of Neuroscience, Imaging and Clinical Sciences, at the University “G. d’Annunzio” of Chieti – Pescara, Italy.
My research focus is on biomedical signal processing, mainly on functional and effective connectivity in adults and children to detect the neural correlates of behavior in studies adopting a multimodal and multidisciplinary approach.
My research is concerned with the mammalian skull and how it has been shaped by both evolution and function. I am interested in how the forces generated by feeding can influence cranial morphology. I investigate these issues using techniques such as geometric morphometrics and finite element analysis. I am fascinated by all mammals, but my current research is particularly focused on the rodents, as they display unique and highly specialised adaptations of the teeth and masticatory muscles.
Affiliation: Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, Wrocław, Poland (Bacteriophage Laboratory).Position: professor.
Current field of interest: non-bactericidal effects of phages in mammals; i.e. phage molecular biology tools for studies of phage impact on immunological system and other physiological aspects in mammals.
Dr Tim Doyle is a biomechanics and physical performance researcher. He has a broad network having studied within Australia (The University of Queensland, Edith Cowan University) and overseas at Ball State University in the USA. In addition to his academic qualifications he is also an accredited level 2 strength and conditioning coach (ASCA) and an accredited level 2 sport scientist (ESSA). He was awarded an Endeavour Executive Fellowship which provided the opportunity to spend time at The Mayo Clinic. His research involves neuromuscular biomechanics, injury prevention, and physical preparation in athletes and tactical populations.